MEI, RICCARDO
MEI, RICCARDO
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot study
2024 Pabst, K. M.; Mei, R.; Luckerath, K.; Hadaschik, B. A.; Kesch, C.; Rawitzer, J.; Kessler, L.; Bodensieck, L. S.; Hamacher, R.; Pomykala, K. L.; Fanti, S.; Herrmann, K.; Fendler, W. P.
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection
2024 Droghetti M.; Bianchi L.; Presutti M.; Vetrone L.; Farolfi A.; Mei R.; Giunchi F.; Degiovanni A.; Mottaran A.; Piazza P.; Cangemi D.; Castellucci P.; D'Errico A.; Schiavina R.; Brunocilla E.; Fanti S.
The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation
2024 Mei, R.; Pyka, T.; Sari, H.; Fanti, S.; Afshar-Oromieh, A.; Giger, R.; Caobelli, F.; Rominger, A.; Alberts, I.
68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
2023 Mei R.; Kessler L.; Pabst K.M.; Weber M.; Schmidkonz C.; Rischpler C.; Zacho H.D.; Hope T.; Schwarzenbock S.M.; Allen-Auerbach M.; Emmett L.; Ferdinandus J.; Unterrainer M.; Schaarschmidt B.M.; Umutlu L.; Farolfi A.; Castellucci P.; Nanni C.; Telo S.; Fanti S.; Herrmann K.; Fendler W.P.
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge
2023 Vetrone L.; Cuzzani G.; Mei R.; Zanoni L.; Bertaccini A.; Bianchi L.; Castellucci P.; Gaudiano C.; Cappelli A.; Giunchi F.; Fanti S.
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging
2023 Vetrone L.; Mei R.; Bianchi L.; Giunchi F.; Farolfi A.; Castellucci P.; Droghetti M.; Presutti M.; Degiovanni A.; Schiavina R.; Brunocilla E.; D'Errico A.; Fanti S.
Potential Clinical Applications of Dedicated Prostate Positron Emission Tomography.
2023 Castellucci P, Mei R, Farolfi A, Nanni C, Fanti S.
Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
2023 Calderoni L, Maietti E, Farolfi A, Mei R, Louie KS, Groaning M, Fanti S.
PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
2023 Bianchi L.; Ceci F.; Balestrazzi E.; Costa F.; Droghetti M.; Piazza P.; Pissavini A.; Presutti M.; Farolfi A.; Mei R.; Castellucci P.; Gandaglia G.; Larcher A.; Robesti D.; Mottrie A.; Briganti A.; Morganti A.G.; Fanti S.; Montorsi F.; Schiavina R.; Brunocilla E.
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence
2023 Bianchi, Lorenzo; Ceci, Francesco; Costa, Francesco; Balestrazzi, Eleonora; Droghetti, Matteo; Piazza, Pietro; Pissavini, Alessandro; Mei, Riccardo; Farolfi, Andrea; Castellucci, Paolo; Puliatti, Stefano; Larcher, Alessandro; Gandaglia, Giorgio; Robesti, Daniele; Mottrie, Alexandre; Briganti, Alberto; Morganti, Alessio Giuseppe; Fanti, Stefano; Montorsi, Francesco; Schiavina, Riccardo; Brunocilla, Eugenio
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more?
2022 Mei, Riccardo; Farolfi, Andrea; Morigi, Joshua James; Fanti, Stefano
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer.
2021 Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, Castellucci P.
Delayed imaging with oral contrast improves [68Ga]Ga-DOTANOC PET/CT detection of primary duodenal neuroendocrine tumor (NET)
2021 Mei R.; Allegri V.; Calabro D.; Fanti S.; Ambrosini V.
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study.
2021 Farolfi A, Hirmas N, Gafita A, Weber M, Barbato F, Wetter A, Mei R, Pianori D, Hadaschik B, Herrmann K, Castellucci P, Fanti S, Eiber M, Fendler WP.
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget.
2021 Mei R, Farolfi A, Castellucci P, Nanni C, Zanoni L, Fanti S.
The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis.
2021 Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S.
Colon Sarcoidosis Mimicking Cancer at 18F-FDG PET/CT
2020 Mei R.; Prediletto I.; Nava S.; Fanti S.; Ambrosini V.
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System
2018 Mei, Riccardo; Raschi, Emanuel; Forcesi, Emanuele; Diemberger, Igor; De Ponti, Fabrizio; Poluzzi, Elisabetta
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature
2018 Mei, Riccardo; Raschi, Emanuel; Poluzzi, Elisabetta; Diemberger, Igor; De Ponti, Fabrizio